Sanj K Patel's Employee Stock Option Exercise at Kiniksa Pharmaceuticals

Sanj K Patel, an officer and director at Kiniksa Pharmaceuticals International, plc, has exercised employee stock options for 257,969 Class A Ordinary Shares. The transaction, which took place on October 20, 2025, was facilitated through a broker payment for a cashless exercise. The shares were acquired from Kiniksa Pharmaceuticals, Ltd., and the aggregate market value of the shares sold is approximately $10,035,561. The shares are listed on NASDAQ, and the broker involved in the transaction is Charles Schwab & Co., Inc. There are no securities sold in the past three months to report.